Intimate partner violence and engagement in HIV care and treatment among women: A systematic review and meta-analysis

AIDS

Volumn 29, Issue 16, 2015, Pages 2183-2194

  Hatcher, Abigail M ^a,b   Smout, Elizabeth M ^c   Turan, Janet M ^d   Christofides, Nicola ^b   Stöckl, Heidi ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

antiretroviral treatment adherence; engagement in care; intimate partner violence; meta analysis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COCAINE;

ARTICLE; ASSESSMENT OF HUMANS; CONFLICT TACTICS SCALE; DEPRESSION; DRUG ABUSE; FEAR; FEMALE; FORCED SEX; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL CARE; MEDICATION COMPLIANCE; META ANALYSIS; MORISKY MEDICATION ADHERENCE SCALE; PARTNER VIOLENCE; PATIENT COMPLIANCE; PATIENT SAFETY; PRIORITY JOURNAL; SELF REPORT; SEVERITY OF VIOLENCE AGAINST WOMEN SCALE; SEXUAL VIOLENCE; SLAPPED THREATENED AND THROW INSTRUMENT; SYSTEMATIC REVIEW; VIRUS LOAD; WOMEN EXPERIECE OF BATTERING SCALE; HIV INFECTIONS; PATHOLOGY; PSYCHOLOGY;

ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INTIMATE PARTNER VIOLENCE; MEDICATION ADHERENCE; VIRAL LOAD;

EID: 84964843188     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000842     Document Type: Article

References (103)

1. Merenstein DJ, Schneider MF, Cox C, Schwartz R, Weber K, Robison E, et al. Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. Pediatrics 2008; 121:e787-e793.
2. Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, et al. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis 2007; 45: 1377-1385.
3. Poundstone KE, Chaisson RE, Moore RD. Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS 2001; 15:1115-1123.
4. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med 2006; 145:397-406.
5. WHO. Primary prevention of intimate-partner violence and sexual violence: background paper for WHO expert meeting. Geneva: World Health Organization; 2007. http://www. who.int/violence-injury-prevention/publications/violence/IPVSV. pdf.
6. Devries KM, Mak JY, Garcia-Moreno C, Petzold M, Child JC, Falder G, et al. The global prevalence of intimate partner violence against women. Science 2013; 340:1527-1528.
7. Maman S, Mbwambo JK, Hogan NM, Kilonzo GP, Campbell JC, Weiss E, et al. HIV-positive women report more lifetime partner violence: findings from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. Am J Public Health 2002; 92:1331-1337.
8. Jewkes RK, Dunkle K, Nduna M, Shai N. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study. Lancet 2010; 376:41-48.
9. Kouyoumdjian FG, Calzavara LM, Bondy SJ, O'Campo P, Serwadda D, Nalugoda F, et al. Intimate partner violence is associated with incident HIV infection in women in Rakai, Uganda. AIDS 2013; 27:1331-1338.
10. Li Y, Marshall CM, Rees HC, Nunez A, Ezeanolue EE, Ehiri JE. Intimate partner violence and HIV infection among women: a systematic review and meta-analysis. J Int AIDS Soc 2014; 17:18845.
11. Dunkle KL, Decker MR. Gender-based violence and HIV: reviewing the evidence for links and causal pathways in the general population and high-risk groups. Am J Reprod Immunol 2013; 69 (Suppl 1):20-26.
12. Decker MR, Seage GR III, Hemenway D, Raj A, Saggurti N, Balaiah D, et al. Intimate partner violence functions as both a risk marker and risk factor for women's HIV infection: findings from Indian husband-wife dyads. J Acquir Immune Defic Syndr 2009; 51:593-600.
13. Stockl H, Kalra N, Jacobi J, Watts C. Is early sexual debut a risk factor for HIV infection among women in sub-Saharan Africa? A systematic review. Am J Reprod Immunol 2013; 69 (Suppl 1):27-40.
14. Cohen M, Deamant C, Barkan S, Richardson J, Young M, Holman S, et al. Domestic violence and childhood sexual abuse in HIV-infected women and women at risk for HIV. Am J Public Health 2000; 90:560-565.
15. Brady S, Gallagher D, Berger J, Vega M. Physical and sexual abuse in the lives of HIV-positive women enrolled in a primary medicine health maintenance organization. AIDS Patient Care STDS 2002; 16:121-125.
16. Vlahov D, Wientge D, Moore J, Flynn C, Schuman P, Schoenbaum E, et al. Violence among women with or at risk for HIV infection. AIDS Behav 1998; 2:53-60.
17. Sowell RL, Phillips KD, Seals B, Murdaugh C, Rush C. Incidence and correlates of physical violence among HIV-infected women at risk for pregnancy in the southeastern United States. J Assoc Nurses AIDS Care 2002; 13:46-58.
18. Borwein A, Salters KA, Palmer AK, Miller CL, Duncan KC, Chan K, et al. High rates of lifetime and recent violence observed among harder-to-reach women living with HIV. AIDS Care 2014; 26:587-594.
19. Fonck K, Leye E, Kidula N, Ndinya-Achola J, Temmerman M. Increased risk of HIV in women experiencing physical partner violence in Nairobi, Kenya. AIDS Behav 2005; 9:335-339.
20. Pence BW, Reif S, Whetten K, Leserman J, Stangl D, Swartz M, et al. Minorities, the poor, and survivors of abuse: HIVinfected patients in the US deep South. South Med J 2007; 100:1114-1122.
21. Zierler S, Cunningham WE, Andersen R, Shapiro MF, Nakazono T, Morton S, et al. Violence victimization after HIV infection in a US probability sample of adult patients in primary care. Am J Public Health 2000; 90:208-215.
22. Ezechi OC, Gab-Okafor C, Onwujekwe DI, Adu RA, Amadi E, Herbertson E. Intimate partner violence and correlates in pregnant HIV positive Nigerians. Arch Gynecol Obstet 2009; 280:745-752.
23. Hatcher AM, Romito P, Odero M, Bukusi EA, Onono M, Turan JM. Social context and drivers of intimate partner violence in rural Kenya: implications for the health of pregnant women. Cult Health Sex 2013; 15:404-419.
24. Shamu S, Zarowsky C, Shefer T, Temmerman M, Abrahams N. Intimate partner violence after disclosure of HIV test results among pregnant women in Harare, Zimbabwe. PLoS One 2014; 9:e109447.
25. Schafer KR, Brant J, Gupta S, Thorpe J, Winstead-Derlega C, Pinkerton R, et al. Intimate partner violence: a predictor of worse HIV outcomes and engagement in care. AIDS Patient Care STDS 2012; 26:356-365.
26. Nava A, Trimble D, McFarlane J. HIV-infected women and intimate partner violence: CD4 counts, opportunistic infections, viral replication, and adherence to antiretroviral medication. 41st Biennial Convention of Sigma Theta Tau International; 28 October-2 November 2011, Grapevine, TX.
27. Liebschutz JM, Feinman G, Sullivan L, Stein M, Samet J. Physical and sexual abuse in women infected with the human immunodeficiency virus: increased illness and healthcare utilization. Arch Intern Med 2000; 160:1659-1664.
28. Weber K, Cole A, Anastos K, Burke-Miller J, Agniel D, Schwartz R, et al. The effect of gender based violence (GBV) on mortality: a longitudinal study of US women with & at risk for HIV. In: AIDS 2012, 17-22 July 2012.
29. Mepham S, Zondi Z, Mbuyazi A, Mkhwanazi N, Newell ML. Challenges in PMTCT antiretroviral adherence in northern KwaZulu-Natal, South Africa. AIDS Care 2011; 23:741-747.
30. Makin JD, Forsyth BW, Visser MJ, Sikkema KJ, Neufeld S, Jeffery B. Factors affecting disclosure in South African HIVpositive pregnant women. AIDS Patient Care STDS 2008; 22:907-916.
31. Tam M, Amzel A, Phelps BR. Disclosure of HIV serostatus among pregnant and postpartum women in sub-Saharan Africa: a systematic review. AIDS Care 2015; 27:436-450.
32. Bajunirwe F, Arts EJ, Tisch DJ, King CH, Debanne SM, Sethi AK. Adherence and treatment response among HIV-1-infected adults receiving antiretroviral therapy in a rural government hospital in Southwestern Uganda. J Int Assoc Physicians AIDS Care (Chic) 2009; 8:139-147.
33. Medley A, Garcia-Moreno C, McGill S, Maman S. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: implications for prevention of mother-to-child transmission programmes. Bull World Health Organ 2004; 82:299-307.
34. Wouters E, van Loon F, van Rensburg D, Meulemans H. Community support and disclosure of HIV serostatus to family members by public-sector antiretroviral treatment patients in the Free State Province of South Africa. AIDS Patient Care STDS 2009; 23:357-364.
35. Hatcher AM, Woollett N, Pallitto C, Mokoatle K, Delany-Moretlwe S, Macphail C, et al. Bidirectional links between HIV and intimate partner violence in pregnancy: implications for prevention of mother-to-child transmission. J Int AIDS Soc 2014; 17:19233.
36. Antelman G, Smith Fawzi MC, Kaaya S, Mbwambo J, Msamanga GI, Hunter DJ, et al. Predictors of HIV-1 serostatus disclosure: a prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS 2001; 15:1865-1874.
37. Kilewo C, Massawe A, Lyamuya E, Semali I, Kalokola F, Urassa E, et al. HIV counseling and testing of pregnant women in sub- Saharan Africa: experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 2001; 28:458-462.
38. Pico-Alfonso MA, Garcia-Linares MI, Celda-Navarro N, Blasco-Ros C, Echebura E, Martinez M. The impact of physical, psychological, and sexual intimate male partner violence on women's mental health: depressive symptoms, posttraumatic stress disorder, state anxiety, and suicide. J Women's Health 2006; 15:599-611.
39. Martinez J, Hosek SG, Carleton RA. Screening and assessing violence and mental health disorders in a cohort of inner city HIV-positive youth between 1998-2006. AIDS Patient Care STDS 2009; 23:469-475.
40. Ellsberg M, Jansen HA, Heise L, Watts CH, Garcia-Moreno C. Intimate partner violence and women's physical and mental health in the WHO multicountry study on women's health and domestic violence: an observational study. Lancet 2008; 371:1165-1172.
41. Ishida K, Stupp P, Melian M, Serbanescu F, Goodwin M. Exploring the associations between intimate partner violence and women's mental health: evidence from a populationbased study in Paraguay. Soc Sci Med 2010; 71:1653-1661.
42. Chandra PS, Satyanarayana VA, Carey MP. Women reporting intimate partner violence in India: associations with PTSD and depressive symptoms. Arch Womens Ment Health 2009; 12:203-209.
43. Mahenge B, Likindikoki S, Stockl H, Mbwambo J. Intimate partner violence during pregnancy and associated mental health symptoms among pregnant women in Tanzania: a cross-sectional study. BJOG 2013; 120:940-946.
44. Sumari-de Boer IM, Sprangers MA, Prins JM, Nieuwkerk PT. HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients. AIDS Behav 2012; 16:1681-1689.
45. Ammassari A, Antinori A, Aloisi MS, Trotta MP, Murri R, Bartoli L, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics 2004; 45:394-402.
46. Cook JA, Cohen MH, Burke J, Grey D, Anastos K, Kirstein L, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr 2002; 30:401-409.
47. Starace F, Ammassari A, Trotta MP, Murri R, De Longis P, Izzo C, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31 (Suppl 3):S136-S139.
48. McCauley J, Yurk RA, Jenckes MW, Ford DE. Inside 'Pandora's box': abused women's experiences with clinicians and health services. J Gen Intern Med 1998; 13:549-555.
49. Lichtenstein B. Domestic violence in barriers to healthcare for HIV-positive women. AIDS Patient Care STDS 2006; 20:122-132.
50. Gari S, Doig-Acuna C, Smail T, Malungo JR, Martin-Hilber A, Merten S. Access to HIV/AIDS care: a systematic review of socio-cultural determinants in low and high income countries. BMC Health Serv Res 2013; 13:198.
51. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6:e1000097.
52. Reuters T. EndNote. New York, NY: Thomson Reuters; 2011.
53. Oram S, Stöckl H, Busza J, Howard LM, Zimmerman C. Prevalence and risk of violence and the physical, mental, and sexual health problems associated with human trafficking: systematic review. PLoS Med 2012; 9:615.
54. Deeks JJ, Higgins J, Altman DG. Analysing data and undertaking meta- analyses. Cochrane Book Series. Chichester, UK: The Cochrane Collaboration and John Wiley & Sons Ltd; 2008; pp. 243-296.
55. Harris R, Bradburn M, Deeks J, Harbord R, Altman D, Sterne J. Metan: fixed-and random-effects meta-analysis. Stata J 2008; 8:3.
56. Sterne JA, Harbord RM. Funnel plots in meta-analysis. Stata J 2004; 4:127-141.
57. Egger M, Smith GD, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997; 315:629-634.
58. Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med 2000; 19:3127-3131.
59. Illangasekare S, Tello M, Hutton H, Moore R, Anderson J, Baron J, et al. Clinical and mental health correlates and risk factors for intimate partner violence among HIV-positive women in an inner-city HIV clinic. Womens Health Issues 2012; 22:e563-e569.
60. Kalokhe AS, Paranjape A, Bell CE, Cardenas GA, Kuper T, Metsch LR, et al. Intimate partner violence among HIV-infected crack cocaine users. AIDS Patient Care STDS 2012; 26:234-240.
61. Lopez EJ, Jones DL, Villar-Loubet OM, Arheart KL, Weiss SM. Violence, coping, and consistent medication adherence in HIV-positive couples. AIDS Educ Prev 2010; 22:61-68.
62. Malow R, Devieux JG, Stein JA, Rosenberg R, Jean-Gilles M, Attonito J, et al. Depression, substance abuse and other contextual predictors of adherence to antiretroviral therapy (ART) among Haitians. AIDS Behav 2013; 17:1221-1230.
63. Ramachandran S, Yonas MA, Silvestre AJ, Burke JG. Intimate partner violence among HIV-positive persons in an urban clinic. AIDS Care 2010; 22:1536-1543.
64. Rose RC, House AS, Stepleman LM. Intimate partner violence and its effects on the health of African American HIV-positive women. Psychol Trauma Theory Res Pract Policy 2010; 2:311-317.
65. Siemieniuk RAC, Krentz HB, Miller P, Woodman K, Ko K, Gill MJ. The clinical implications of high rates of intimate partner violence against HIV-positive women. J Acquir Immune Defic Syndr 2013; 64:32-38.
66. Trimble DD, Nava A, McFarlane J. Intimate partner violence and antiretroviral adherence among women receiving care in an urban Southeastern Texas HIV clinic. J Assoc Nurses AIDS Care 2013; 24:331-340.
67. Blackstock OJ, Blank AE, Fletcher JJ, Verdecias N, Cunningham CO. Considering care-seeking behaviors reveals important differences among HIV-positive women not engaged in care: implications for intervention. AIDS Patient Care STDS 2015; 29 (Suppl 1):S20-S26.
68. Ryerson Espino S, Fletcher J, Gonzalez M, Precht A, Xavier J, Matoff-Stepp S. Violence screening and viral load suppression among HIV-positive women of color. AIDS Patient Care STDS 2015; 29 (Suppl 1):S36-S41.
69. Sullivan KA, Messer LC, Quinlivan EB. Substance abuse, violence, and HIV/AIDS (SAVA) syndemic effects on viral suppression among HIV positive women of color. AIDS Patient Care STDS 2015; 29 (Suppl 1):S42-S48.
70. Blank AE, Fletcher J, Verdecias N, Garcia I, Blackstock O, Cunningham C. Factors associated with retention and viral suppression among a cohort of HIVR women of color. AIDS Patient Care STDS 2015; 29 (Suppl 1):S27-S35.
71. Siemieniuk RA, Krentz HB, Gish JA, Gill MJ. Domestic violence screening: prevalence and outcomes in a Canadian HIV population. AIDS Patient Care STDS 2010; 24:763-770.
72. Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Hafsteinsdottir TB, Richter C, et al. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med 2014; 12:142.
73. Mugavero M, Ostermann J, Whetten K, Leserman J, Swartz M, Stangl D, et al. Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events. AIDS Patient Care STDS 2006; 20:418-428.
74. Cohen MH, Cook JA, Grey D, Young M, Hanau LH, Tien P, et al. Medically eligible women who do not use HAART: the importance of abuse, drug use, and race. Am J Public Health 2004; 94:1147-1151.
75. Dale S, Cohen M, Weber K, Cruise R, Kelso G, Brody L. Abuse and resilience in relation to HAART medication adherence and HIV viral load among women with HIV in the United States. AIDS Patient Care STDS 2014; 28:136-143.
76. Jones AS, Lillie-Blanton M, Stone VE, Ip EH, Zhang Q, Wilson TE, et al. Multi-dimensional risk factor patterns associated with non-use of highly active antiretroviral therapy among human immunodeficiency virus-infected women. Womens Health Issues 2010; 20:335-342.
77. Machtinger EL, Haberer JE, Wilson TC, Weiss DS. Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and femaleidentified transgenders. AIDS Behav 2012; 16:2160-2170.
78. Mugavero MJ, Raper JL, Reif S, Whetten K, Leserman J, Thielman NM, et al. Overload: impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study. Psychosom Med 2009; 71:920-926.
79. Pence BW, Ostermann J, Kumar V, Whetten K, Thielman N, Mugavero MJ. The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy. J Acquir Immune Defic Syndr 2008; 47:194-201.
80. Liebschutz JM, Geier JL, Horton NJ, Chuang CH, Samet JH. Physical and sexual violence and healthcare utilization in HIV-infected persons with alcohol problems. AIDS Care 2005; 17:566-578.
81. Shah PS, Shah J, Knowledge Synthesis Group on Determinants of Preterm LBWB. Maternal exposure to domestic violence and pregnancy and birth outcomes: a systematic review and meta-analyses. J Womens Health (Larchmt) 2010; 19:2017-2031.
82. O'Reilly R, Beale B, Gillies D. Screening and intervention for domestic violence during pregnancy care: a systematic review. Trauma Violence Abuse 2010; 11:190-201.
83. WHO. Global and regional estimates of violence against women: prevalence and health effects of intimate partner violence and nonpartner sexual violence. Geneva: World Health Organization; 2013.
84. WHO, UNICEF, UNAIDS. Global update on HIV treatment 2013: results, impact and opportunities. Geneva: World Health Organization; 2013. http://apps.who.int/iris/bitstream/ 10665/85326/1/9789241505734-eng.pdf. [accessed 13 August 2015]
85. Were E, Curran K, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Kiarie J, et al. A prospective study of frequency and correlates of intimate partner violence among African heterosexual HIVserodiscordant couples. AIDS2011; 25:2009-2018.
86. Darbes L, Chakravarty D, Leddy A, Dladla S, de Bruyn G. Sexual communication self-efficacy (SCSE) is a significant predictor of participating in couples-based voluntary counseling and testing (CBVCT) for HIV in Soweto. Washington, DC: IAC; 2012.
87. Mugavero MJ, Westfall AO, Zinski A, Davila J, Drainoni M-L, Gardner LI, et al. Measuring retention in HIV care: the elusive gold standard. J Acquir Immune Defic Syndr 2012; 61:574.
88. Stockman JK, Campbell JC, Celentano DD. Sexual violence and HIV risk behaviors among a nationally representative sample of heterosexual American women: the importance of sexual coercion. J Acquir Immune Defic Syndr 2010; 53:136-143.
89. Garcia-Moreno C, Jansen HA, Ellsberg M, Heise L, Watts CH. Prevalence of intimate partner violence: findings from the WHO multicountry study on women's health and domestic violence. Lancet 2006; 368:1260-1269.
90. WHO. Putting women first: ethical and safety recommendations for research on domestic violence against women. Geneva: Department of Gender and Women's Health, World Health Organisation; 2001.
91. WHO. Responding to intimate partner violence and sexual violence against women: WHO clinical and policy guidelines. Geneva: World Health Organization; 2013.
92. Gari S, Martin-Hilber A, Malungo JR, Musheke M, Merten S. Sex differentials in the uptake of antiretroviral treatment in Zambia. AIDS Care 2014; 26:1258-1262.
93. Mutasa-Apollo T, Shiraishi RW, Takarinda KC, Dzangare J, Mugurungi O, Murungu J, et al. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010. PLoS One 2014; 9:e86305.
94. Pantalone DW, Hessler DM, Simoni JM. Mental health pathways from interpersonal violence to health-related outcomes in HIV-positive sexual minority men. J Consult Clin Psychol 2010; 78:387-397.
95. Siemieniuk RA, Miller P, Woodman K, Ko K, Krentz HB, Gill MJ. Prevalence, clinical associations, and impact of intimate partner violence among HIV-infected gay and bisexual men: a population-based study. HIV Med 2013; 14:293-302.
96. United States Government. Addressing the intersection of HIV/ AIDS, violence against women and girls, & gender-related health disparities: interagency Federal Working Group Report. Washington: White House Working Group; 2013.
97. USAID. Gender-based violence and HIV: a program guide for integrating gender-based violence prevention and response in PEPFAR programs. Washington: USAID; 2009.
98. Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, Ram M, et al. Depression, alcohol use and adherence to antiretroviral therapy in sub-Saharan Africa: a systematic review. AIDS Behav 2012; 16:2101-2118.
99. Moyer VA. Screening for intimate partner violence and abuse of elderly and vulnerable adults: US Preventive Services Task Force recommendation statement. Ann Intern Med 2013; 158:478-486.
100. Machtinger EL, Cuca YP, Khanna N, Rose CD, Kimberg LS. From treatment to healing: the promise of trauma-informed primary care. Women's Health Issues 2015; 25:193-197.
101. Turan JM, Hatcher AM, Odero M, Onono M, Kodero J, Romito P, et al. A community-supported clinic-based program for prevention of violence against pregnant women in rural Kenya. AIDS Res Treat 2013; 2013:e1-e10.
102. Wagman JA, Gray RH, Campbell JC, Thoma M, Ndyanabo A, Ssekasanvu J, et al. Effectiveness of an integrated intimate partner violence and HIV prevention intervention in Rakai, Uganda: analysis of an intervention in an existing cluster randomised cohort. Lancet Global Health 2015; 3:e23-e33.
103. Wyatt GE, Hamilton AB, Myers HF, Ullman JB, Chin D, Sumner LA, et al. Violence prevention among HIV-positive women with histories of violence: healing women in their communities. Women's Health Issues 2011; 21:S255-S260.